New assays based on nanotechnology and stem cell science promise to reduce the need for laboratory animals while increasing the success rate of new leads.
Industry-Academia collaborations may pay off with hESC-based drug screening advances.
Ricerca Biosciences, a uniquely integrated preclinical contract research organization providing services to the biopharmaceutical industry, announced that Michael E. Placke, PhD, DABT, will join Ricerca as senior vice president and general manager at their Concord, Ohio, facility.
With the help of a highly sensitive Andor iXon+ EMCCD camera, US researchers have developed a super-resolution, 3D imaging technique that can resolve single fluorescent molecules with greater than 10 times more precision than conventional optical microscopy.
Fluidigm Corporation introduced its FC1 Cycler designed to reduce the thermal cycling time by a factor of three when compared with the company’s current products.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Lewy Body Dementia Association (LBDA) announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program.
The National Organization for Rare Disorders (NORD) will honor two trailblazing scientists, a pioneering patient organization, and five companies that have brought innovative new treatments to market for rare diseases at the 2010 NORD Partners in Progress Gala.
Patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives, according to researchers at Thomas Jefferson University.
Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated.
Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings.
A jury decided that the drug company Novartis engaged in a pattern of discrimination against women, paying them less than men, cheating them of promotions and treating pregnant women unfavorably.
Advances in electron microscopy reveal new opportunities in drug discovery and development.
In this issue’s cover story, we address the search for alternatives to animal testing for drug safety. Using animal models to test the safety of drugs for humans has long been a controversial topic.
Vaccinogen selected Clinipace Worldwide to manage a Phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.
CEDRA Corporation (Austin, Tex.), a division of Worldwide Clinical Trials (WCT) and a provider of Phase 1 clinical research and bioanalytical services, announced that Anthony G. Busa, Jr., has been named chief executive officer.